The clinical analysis of acute pancreatitis in colorectal cancer patients undergoing chemotherapy after operation

Yanlei Ji1 Department of Special Diagnosis, Shandong Cancer Hospital and Institute, Jinan, People’s Republic of China

Zhen Han2 Department of Internal Medicine, Jinan Second People’s Hospital, Jinan, People’s Republic of China

Limei Shao1 Department of Special Diagnosis, Shandong Cancer Hospital and Institute, Jinan, People’s Republic of China

Yunling Li1 Department of Special Diagnosis, Shandong Cancer Hospital and Institute, Jinan, People’s Republic of China

Long Zhao1 Department of Special Diagnosis, Shandong Cancer Hospital and Institute, Jinan, People’s Republic of China

Yuehuan Zhao1 Department of Special Diagnosis, Shandong Cancer Hospital and Institute, Jinan, People’s Republic of ChinaCorrespondence[email protected]

Pages 2527-2533 | Published online: 11 Sep 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

GrossoFMandalaMMaglioneVNeoadjuvant therapy and mini-invasive total mesorectal excision for rectal cancer: feasibility and outcome analysis from a single institution prospectively collected data baseTumori20129868969523389353
PubMed Web of Science ®Google Scholar
Maindrault-GoebelFLouvetCAndréTOxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy formetastatic colorectal cancer (FOLFOX6)Eur J Cancer1999351338134210658524
PubMed Web of Science ®Google Scholar
TwelvesCCan capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer?Oncology200216232612520636
PubMed Web of Science ®Google Scholar
De GramontAFigerASeymourMLeucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerJ Clin Oncol2000182938294710944126
PubMed Web of Science ®Google Scholar
KanekoJAoyagiHYoshidaTA patient with sigmoid colon cancer (c Stage IV) who responded to preoperative chemotherapy with mFOLFOX6 plus bevacizumab and was subsequently able to undergo a radical operationGan To Kagaku Ryoho2012392204220623268024
PubMedGoogle Scholar
MichaelMZalcbergJGibbsPA phase I trial of imatinib in combination with mFOLFOX6-bevacizumab in patients with advanced colorectal cancerCancer Chemother Pharmacol20137132133023108698
PubMed Web of Science ®Google Scholar
KatoKInabaYTsujiYA multicenter phase-II study of 5-FU, leucovorin and oxaliplatin (FOLFOX6) in patients with pretreated metastatic colorectal cancerJpn J Clin Oncol201141636820819832
PubMed Web of Science ®Google Scholar
AlianOMAzmiASMohammadRMNetwork insights on oxaliplatin anti-cancer mechanismsClin Transl Med201212623369220
PubMedGoogle Scholar
ShoeibTSharpBLInteractions of oxaliplatin with the cytoplasmic thiol containing ligand glutathioneMetallomics20124121308132023128601
PubMed Web of Science ®Google Scholar
MowakaSZieheMMohamedDStructures of oxaliplatin- oligonucleotide adducts from DNAJ Mass Spectrom2012471282129323019159
PubMed Web of Science ®Google Scholar
CassidyJMissetJLOxaliplatin-related side effects: characteristics and managementSemin Oncol2002295 Suppl 15112012422304
PubMed Web of Science ®Google Scholar
LeeHHHurHKimSHParkARKimWJeonHMOutcomes of modified FOLFOX-6 as first line treatment in patients with advanced gastric cancer in a single institution; retrospective analysisCancer Res Treat201042182320369047
PubMed Web of Science ®Google Scholar
ShioiriMHasegawaMTanakaHTwo cases of interstitial pneumonia caused by cetuximab plus mFOLFOX6 therapy in metastatic colorectal cancer patientsGan To Kagaku Ryoho2012392198220023268022
PubMedGoogle Scholar
ManegoldCGatzemeierUvon PawelJA case of 5-fluorouracil-induced hyperammmonia after chemotherapy for metastatic colon cancerNihon Shokakibyo Gakkai Zasshi20091061744175019966516
PubMedGoogle Scholar
GillSGoldbergRMFirst-line treatment strategies to improve survival in patients with advanced colorectal cancerDrugs200464274414723557
PubMed Web of Science ®Google Scholar
NishiTHamamotoYUemotoJModified FOLFOX6 (mFOLFOX6) in metastatic colorectal carcinoma patients with poor performance statusGan To Kagaku Ryoho2012392557256023235179
PubMedGoogle Scholar
HoffPMHochhausAPestalozziBCCediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II)J Clin Oncol2012303596360322965965
PubMed Web of Science ®Google Scholar
TsutsumiSWatanabeRTabeYScheduled prospective tri-weekly modified FOLFOX6 maintenance chemotherapy in the treatment of metastatic colorectal cancerHepatogastroenterology2011581930193222234064
PubMedGoogle Scholar
HealeyEStillfriedGEEckermannSComparative effectiveness of 5-fluorouracil with and without oxaliplatin in the treatment of colorectal cancer in clinical practiceAnticancer Res2013331053106023482781
PubMed Web of Science ®Google Scholar
ChenMLFangCHLiangLSA meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancerSurg Oncol201019384519345093
PubMed Web of Science ®Google Scholar
PetrovMSEditorial: abdominal fat: a key player in metabolic acute pancreatitisAm J Gastroenterol201310814014223287945
PubMed Web of Science ®Google Scholar
Sadr-AzodiOOrsiniNAndren-SandbergAAbdominal and total adiposity and the risk of acute pancreatitis: a population-based prospective cohort studyAm J Gastroenterol201310813313923147519
PubMed Web of Science ®Google Scholar
Guzman CalderonEMontes TevesPMonge SalgadoEBisap-O: obesity included in score BISAP to improve prediction of severity in acute pancreatitisRev Gastroenterol Peru20123225125623128944
PubMedGoogle Scholar
ChenSMXiongGSWuSMIs obesity an indicator of complications and mortality in acute pancreatitis? An updated meta-analysisJ Dig Dis20121324425122500786
PubMed Web of Science ®Google Scholar
Al-SuhaimiEAShehzadALeptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunityEur J Med Res2013181223634778
PubMed Web of Science ®Google Scholar
LiangCLiaoJDengZLeptin attenuates lipopolysaccharide- induced apoptosis of thymocytes partially via down-regulation of cPLA2 and p38 MAPK activationInt Immunopharmacol20131562062723376443
PubMed Web of Science ®Google Scholar
BehnesMBrueckmannMLangSAlterations of leptin in the course of inflammation and severe sepsisBMC Infect Dis20121421722973876
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The clinical analysis of acute pancreatitis in colorectal cancer patients undergoing chemotherapy after operation

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The clinical analysis of acute pancreatitis in colorectal cancer patients undergoing chemotherapy after operation

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date